[{"Assets_0_FY_USD":226348000.0,"CommonStockSharesOutstanding_0_FY_shares":36975203.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":-104246000.0,"NetIncomeLoss_4_FY_USD":-142568000.0,"NetIncomeLoss_1_FY_USD":-40616000.0,"StockholdersEquity_0_FY_USD":145622000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190228"}]